Wed, November 16, 2022
Tue, November 15, 2022
Mon, November 14, 2022
Fri, November 11, 2022
Thu, November 10, 2022

Chris Schott Downgraded (TEVA) to Sell and Decreased Target to $10 on, Nov 14th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-decreased-target-to-10-on-nov-14th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Chris Schott of JP Morgan, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Sell and Decreased Target from $11 to $10 on, Nov 14th, 2022.

Chris has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 2 agree with Chris's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gary Nachman of "BMO Capital" Maintained at Hold with Decreased Target to $10 on, Monday, November 7th, 2022
  • Nathan Rich of "Goldman Sachs" Maintained at Hold with Increased Target to $10 on, Tuesday, August 2nd, 2022


These are the ratings of the 2 analyists that currently disagree with Chris


  • Glen Santangelo of "Jefferies" Initiated at Strong Buy and Held Target at $10 on, Friday, October 21st, 2022
  • Jason Gerberry of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $13 on, Friday, August 5th, 2022

Publication Contributing Sources